QIAGEN N.V. (QGEN) stock
QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$49.75−0.06 (-0.12%)
Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%
Qiagen operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was $654.33M, down 2.9% from the year before. Over ten years it grew 7.5% a year on average. The highest annual figure on record is $715.26M in fiscal 2022.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $654.33M | -2.9% |
| FY2024 | Dec 31, 2024 | $673.55M | +46.6% |
| FY2023 | Dec 31, 2023 | $459.46M | -35.8% |
| FY2022 | Dec 31, 2022 | $715.26M | +11.9% |
| FY2021 | Dec 31, 2021 | $639.00M | +39.6% |
| FY2020 | Dec 31, 2020 | $457.81M | +38.4% |
| FY2019 | Dec 31, 2019 | $330.84M | -8.0% |
| FY2018 | Dec 31, 2018 | $359.50M | +25.4% |
| FY2017 | Dec 31, 2017 | $286.78M | -16.0% |
| FY2016 | Dec 31, 2016 | $341.60M | +7.6% |
| FY2015 | Dec 31, 2015 | $317.50M | +10.3% |
| FY2014 | Dec 31, 2014 | $287.97M | +11.2% |
| FY2013 | Dec 31, 2013 | $258.96M | +5.7% |
| FY2012 | Dec 31, 2012 | $244.88M | +0.0% |
| FY2011 | Dec 31, 2011 | $244.78M | -2.4% |
| FY2010 | Dec 31, 2010 | $250.75M | +15.6% |
| FY2009 | Dec 31, 2009 | $217.00M | +25.4% |
| FY2008 | Dec 31, 2008 | $173.00M | – |
See a number that looks wrong?